S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

EGRX Eagle Pharmaceuticals Inc

2.14

0.00 (0.00%)

Jan 30 2025 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Eagle Pharmaceuticals Charts.

Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Eagle Pharmaceuticals Charts.

Eagle Pharmaceuticals Inc News

Form EFFECT - Notice of Effectiveness
Monday 9 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 2 December 2024 (2 months ago) • Edgar (US Regulatory)

Form RW - Registration Withdrawal Request
Wednesday 27 November 2024 (2 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Wednesday 27 November 2024 (2 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Wednesday 27 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 27 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
Tuesday 26 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 19 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Tuesday 12 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (3 months ago) • Edgar (US Regulatory)

More Eagle Pharmaceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions